BBIO

BridgeBio Pharma, Inc.$74.48+3.43% 1D· price as of Jun 30, 8:32 PM

Universe

+66.03% over 1Y

Compare:BBIO

Mkt Cap

$14.6B

P/E

—

Fwd P/E

141.3×

PEG

—

P/B

—

P/S

25.2×

EV/EBITDA

—

Beta

0.97

Div Yield

—

Payout

0.0%

ROE

—

Net Margin

-124.4%

Short % Flt

16.6%

Inst. Own

103.2%

52-wk low $41.80$74.4852-wk high $84.94

+78.2% above low-12.3% from high

Seasonality — avg monthly return

Strongest Jul 19.7% · weakest Apr -8.8%

Jan

-4.8

Feb

+2.4

Mar

+10.6

Apr

-8.8

May

-3.8

Jun

+15.0

Jul

+19.7

Aug

+3.5

Sep

-6.4

Oct

+4.3

Nov

+2.6

Dec

-5.9

Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.

Ask AI about BridgeBio Pharma, Inc.

Gemini · web search

Searches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.

BBIO — recent news

Loading headlines…